Johann Bauersachs Selected Research

Bromocriptine (Parlodel)

3/2020	Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
1/2020	Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers.
12/2019	Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
3/2019	Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
1/2019	Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
11/2018	Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'.
10/2018	Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'.
5/2018	Bromocriptine for the Treatment of Peripartum Cardiomyopathy.
12/2017	Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy.
9/2017	Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johann Bauersachs Research Topics

Disease

127	Heart Failure 10/2022 - 01/2002
79	Myocardial Infarction 01/2022 - 01/2002
26	Cardiomyopathies (Cardiomyopathy) 02/2022 - 08/2008
24	Infarction (Infarctions) 01/2022 - 06/2002
22	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 07/2005
21	Inflammation (Inflammations) 06/2022 - 01/2004
19	Fibrosis (Cirrhosis) 01/2022 - 11/2003
16	Cardiomegaly (Heart Hypertrophy) 01/2022 - 11/2002
15	Ventricular Remodeling 01/2019 - 06/2002
13	Coronary Artery Disease (Coronary Atherosclerosis) 12/2017 - 07/2005
12	Hypertrophy 10/2021 - 04/2002
12	Atherosclerosis 01/2021 - 08/2002
11	ST Elevation Myocardial Infarction 12/2022 - 04/2014
11	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 08/2007
10	Atrial Fibrillation 12/2022 - 08/2013
10	Neoplasms (Cancer) 01/2021 - 01/2013
9	Stroke (Strokes) 01/2022 - 02/2009
9	Heart Diseases (Heart Disease) 04/2021 - 11/2006
8	Diabetes Mellitus 02/2022 - 09/2004
8	Out-of-Hospital Cardiac Arrest 01/2022 - 01/2018
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2005
8	Hypertension (High Blood Pressure) 01/2020 - 06/2004
8	Left Ventricular Dysfunction 10/2019 - 11/2003
7	Cardiogenic Shock 01/2022 - 01/2017
7	Acute Coronary Syndrome 01/2022 - 06/2007
7	Thrombosis (Thrombus) 06/2021 - 05/2007
7	Body Weight (Weight, Body) 01/2021 - 01/2002
7	Vascular System Injuries 01/2021 - 01/2004
6	Neointima 01/2021 - 12/2002
6	Cicatrix (Scar) 01/2021 - 06/2002
6	Ischemia 12/2011 - 04/2005
6	Reperfusion Injury 12/2011 - 01/2005
5	Hemorrhage 01/2022 - 01/2017
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 10/2015
5	Congenital Heart Defects (Congenital Heart Defect) 01/2020 - 01/2012
4	Hypoxia (Hypoxemia) 01/2022 - 09/2006
4	Vascular Diseases (Vascular Disease) 01/2020 - 01/2004
4	Pulmonary Edema 01/2019 - 08/2008
4	Atherosclerotic Plaque (Atheroma) 10/2018 - 01/2008

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2009
19	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2022 - 06/2003
19	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2003
15	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2007
13	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 06/2003
13	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 11/2002
11	salicylhydroxamic acid (SHAM)IBA 10/2020 - 01/2002
11	Bromocriptine (Parlodel)FDA LinkGeneric 03/2020 - 11/2015
10	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 09/2014
10	Pharmaceutical PreparationsIBA 11/2021 - 01/2004
10	AldosteroneIBA 01/2020 - 11/2003
9	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2012
9	CollagenIBA 01/2021 - 06/2002
9	CytokinesIBA 01/2020 - 03/2003
9	Eplerenone (Inspra)FDA LinkGeneric 12/2017 - 06/2003
8	RNA (Ribonucleic Acid)IBA 10/2022 - 06/2017
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2002
8	Clopidogrel (Plavix)FDA Link 07/2011 - 12/2004
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2007
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021 - 12/2008
7	Chemokine ReceptorsIBA 10/2020 - 06/2015
7	Chemokine CX3CL1IBA 01/2018 - 01/2004
7	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2016 - 08/2002
7	erucylphosphocholineIBA 05/2011 - 07/2005
6	ProlactinIBA 03/2020 - 11/2015
6	Superoxides (Superoxide)IBA 07/2014 - 01/2002
5	Messenger RNA (mRNA)IBA 06/2022 - 04/2002
5	SodiumIBA 01/2021 - 04/2007
5	Transcription Factors (Transcription Factor)IBA 01/2012 - 09/2004
5	Nitric Oxide Synthase (NO Synthase)IBA 07/2010 - 11/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 11/2002
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2008 - 01/2002
5	NF-kappa B (NF-kB)IBA 08/2007 - 03/2003
4	Prasugrel Hydrochloride FDA Link 12/2022 - 01/2016
4	Natriuretic PeptidesIBA 10/2022 - 01/2019
4	DiureticsIBA 01/2022 - 06/2006
4	IronIBA 10/2021 - 01/2017
4	EnzymesIBA 01/2021 - 09/2007
4	SymportersIBA 01/2021 - 10/2019
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 08/2011
4	Finasteride (Propecia)FDA LinkGeneric 12/2019 - 03/2015
4	Spironolactone (Aldactone)FDA LinkGeneric 12/2017 - 01/2002
4	C-Reactive ProteinIBA 10/2015 - 12/2006
4	ChemokinesIBA 06/2015 - 01/2004
4	AntagomirsIBA 01/2012 - 09/2008
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2009 - 01/2002
4	Endothelins (Endothelin)IBA 01/2004 - 04/2002
3	RivaroxabanIBA 01/2022 - 08/2013
3	finerenoneIBA 01/2022 - 01/2017
3	TroponinIBA 01/2022 - 09/2015

Therapy/Procedure

84	Therapeutics 12/2022 - 04/2002
12	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
12	Ligation 01/2019 - 04/2005
9	Extracorporeal Membrane Oxygenation 01/2021 - 01/2017
7	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 03/2022 - 09/2012
7	Defibrillators (Defibrillator) 12/2021 - 12/2014
7	Percutaneous Coronary Intervention 06/2021 - 01/2011
6	Heart-Assist Devices 01/2022 - 01/2015
5	Cardiopulmonary Resuscitation (CPR) 01/2022 - 01/2016
5	Induced Hypothermia 11/2021 - 01/2016
5	Stents 06/2021 - 12/2004